Hyong Kim Sells 16,506 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 16,506 shares of the company’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total transaction of $352,403.10. Following the sale, the insider directly owned 333,133 shares in the company, valued at $7,112,389.55. This trade represents a 4.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Hyong Kim also recently made the following trade(s):

• On Monday, December 29th, Hyong Kim sold 12,694 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total transaction of $237,885.56.
• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03.
• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.29, for a total value of $581,894.95.

Alignment Healthcare Price Performance

Alignment Healthcare stock traded up $0.30 during midday trading on Tuesday, hitting $21.30. 3,772,138 shares of the company’s stock were exchanged, compared to its average volume of 3,136,679. The company has a market cap of $4.26 billion, a P/E ratio of -177.50, a PEG ratio of 5.81 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The stock has a 50-day moving average price of $18.43 and a two-hundred day moving average price of $16.38. Alignment Healthcare, Inc. has a 52-week low of $11.35 and a 52-week high of $21.65.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm had revenue of $993.70 million during the quarter, compared to the consensus estimate of $980.90 million. During the same quarter last year, the company posted ($0.14) EPS. The company’s revenue for the quarter was up 43.5% on a year-over-year basis. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors have recently bought and sold shares of ALHC. GAMMA Investing LLC grew its position in Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares during the last quarter. Mirabella Financial Services LLP bought a new stake in Alignment Healthcare in the third quarter valued at approximately $186,000. Hudson Bay Capital Management LP purchased a new stake in shares of Alignment Healthcare during the third quarter valued at approximately $4,581,000. Allworth Financial LP grew its holdings in shares of Alignment Healthcare by 28.3% in the third quarter. Allworth Financial LP now owns 6,351 shares of the company’s stock worth $111,000 after purchasing an additional 1,402 shares during the last quarter. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of Alignment Healthcare in the third quarter worth $272,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ALHC has been the subject of a number of research analyst reports. KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a report on Monday, November 24th. JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. The Goldman Sachs Group reiterated a “buy” rating and set a $22.00 price objective on shares of Alignment Healthcare in a research report on Monday, November 3rd. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $21.25.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.